NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
23/06/2026
Voltar para busca
Dado oficial do USPTO
METIRRA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
24
Atualização mais recente
23/06/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 44
Data de depósito
09/07/2025
Data de registro
23/06/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
23/06/2026
Última transação
23/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
AU
Examinador
TENG, SIMON
Unidade examinadora
L50
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Metirra Pty Ltd
Envision Sciences Pty Ltd
Representantes
Carrie Hedayati LOCH APC
Classificação técnica
Classes Nice
Classe 5Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical products for the prevention and treatment of cancer; medical preparations for the treatment of cancer; pharmaceutical and veterinary preparations and substances for the treatment of cancerous tumors; medical biological preparations and substances for the prevention and treatment of infectious diseases; diagnostic biomarker reagents for medical purposes; diagnostic biomarkers for in vitro testing for medical use; diagnostic biomarkers for use in assessment of genomic analysis for medical use; diagnostic biomarkers for use in assessment of chemical skin sensitizers for medical use; diagnostic biomarkers for use in assessment of toxicological property of chemical compounds and mixtures for medical use; biopharmaceuticals for the treatment of cancer; biotechnological preparations for medical purposes and medical usebiological reagents for medical purposes; biocides; diagnostic biomarkers for use in assessment of chemical respiratory sensitizers for medical use; diagnostic reagents and assays for detecting antigens for medical purposes; biotherapeuticstherapeutic pharmaceutical for the treatment of cancer; pharmaceutical biosimilars for human use for the treatment of cancer; medical preparationsimmunotherapeutic agents for the treatment and prevention of cancers and tumors; diagnostic biomarkers and medical antibodies for use in medical imaging
Classe 44
Disease diagnosis services being performing diagnosis of diseases; medical analysis for the diagnosis and treatment of persons; medical analysis services for the diagnosis and treatment of persons; medical analysis services for cancer diagnosis and prognosis; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical services; medical servicesconsulting services in the field of healthcare; medical consultancy services; provision of information in the field of cancer preventionscreeningdiagnosistreatment; RNA or DNA analysis for cancer diagnosis and prognosis; medical pathology services; medical services in the field of oncology; providing medical information to patients and medical professionals in the form of medical reports in the field of cancer preventionscreeningdiagnosistreatment; medical information; consulting services in the field of medical care
Publicações
Histórico de despachos e eventos da marca no USPTO.
24 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
23/06/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/05/2026
PUBO
PUBLISHED FOR OPPOSITION
05/05/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
29/04/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/04/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/04/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/04/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/04/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
13/03/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
13/03/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
13/03/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
13/03/2026
RFNT
REFUSAL PROCESSED BY IB
12/03/2026
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
26/02/2026
RFRR
REFUSAL PROCESSED BY MPU
26/02/2026
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
30/01/2026
CNRT
NON-FINAL ACTION WRITTEN
29/01/2026
DOCK
ASSIGNED TO EXAMINER
29/01/2026
MAFR
APPLICATION FILING RECEIPT MAILED
28/01/2026
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
28/01/2026
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
22/01/2026
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
26/09/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
18/09/2025
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace METIRRA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.